Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy
To determine if transcatheterembolotherapy is safe and effective for the treatment of pulmonaryarteriovenous malformations during pregnancy. Prospective study. Specialized hereditaryhemorrhagic telangiectasia centers at Yale University School of, Medicine and St. Michael's Hospital, University...
Gespeichert in:
| Veröffentlicht in: | Chest 2001-02, Vol.119 (2), p.470-477 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 477 |
|---|---|
| container_issue | 2 |
| container_start_page | 470 |
| container_title | Chest |
| container_volume | 119 |
| creator | Gershon, Andrea S. Faughnan, Marie E. Chon, Kenneth S. Pugash, Robyn A. Clark, John A. Bohan, Michael J. Henderson, Katherine J. Hyland, Robert H. White, Robert I. |
| description | To determine if transcatheterembolotherapy is safe and effective for the treatment of pulmonaryarteriovenous malformations during pregnancy.
Prospective study.
Specialized hereditaryhemorrhagic telangiectasia centers at Yale University School of, Medicine and St. Michael's Hospital, University of Toronto.
Seven pregnant women (age range, 24 to 34 years; gestational age range, 16 to 36 weeks) undergoing transcatheterembolotherapy.
Transcatheterembolotherapy in all patients.
Thirteen pulmonary arteriovenous malformations in sevenpatients were embolized with detachable silicone balloons and/orstainless steel coils without incident. The estimated fetal radiationdose ranged from < 50 to 220 mrad. No complications of pulmonaryarteriovenous malformations occurred in any of the patients aftertranscatheter embolotherapy. The mothers went on to deliver healthybabies in all cases.
Transcatheterembolotherapy of maternal pulmonary arteriovenous malformationsperformed by an experienced radiologist appears to be safe andeffective after 16 weeks of gestational age. |
| doi_str_mv | 10.1378/chest.119.2.470 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70625088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369215382246</els_id><sourcerecordid>70625088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-6c02e0391f58add076e91f70e9f849172b71c235009b2cc897452c6644e9bf513</originalsourceid><addsrcrecordid>eNp1kEtP3DAQgC1EVRbomRuKhNRbFj-SOD4ioLQSVTnQK5bjTHaNHHuxE6r99x26q9JLT_aMvnl9hJwxumRCtpd2DXlaMqaWfFlJekAWTAlWiroSh2RBKeOlaBQ_Isc5P1OMmWo-kiPGmGSS1wvy9JhMyNZMa5ggFbdjF33EIJnNtohD8d1gOhhfPMx-jMGkbXGVMOXiK4Q4ZwT8ENNoJhdDLm7m5MKqeEiwCibY7Sn5MBif4dP-PSE_v9w-Xn8t73_cfbu-ui-tUHwqG0s5UKHYULem76lsAP-SghraSuGmnWSWi5pS1XFrWyWrmtumqSpQ3VAzcUI-7_puUnyZ0YkeXbbgvQmAW2pJG17TtkXwcgfaFHNOMOhNciOepRnVb0r1H6UaRWmuUSlWnO9bz90I_Tu_d4jAxR4wKNIPKNS6_JdrVcUUfx-8dqv1L5dA59F4j03FbuRznN9E_ztY7SoAxb06SDpbB8FCj9V20n10_136N8TKpR0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70625088</pqid></control><display><type>article</type><title>Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Gershon, Andrea S. ; Faughnan, Marie E. ; Chon, Kenneth S. ; Pugash, Robyn A. ; Clark, John A. ; Bohan, Michael J. ; Henderson, Katherine J. ; Hyland, Robert H. ; White, Robert I.</creator><creatorcontrib>Gershon, Andrea S. ; Faughnan, Marie E. ; Chon, Kenneth S. ; Pugash, Robyn A. ; Clark, John A. ; Bohan, Michael J. ; Henderson, Katherine J. ; Hyland, Robert H. ; White, Robert I.</creatorcontrib><description>To determine if transcatheterembolotherapy is safe and effective for the treatment of pulmonaryarteriovenous malformations during pregnancy.
Prospective study.
Specialized hereditaryhemorrhagic telangiectasia centers at Yale University School of, Medicine and St. Michael's Hospital, University of Toronto.
Seven pregnant women (age range, 24 to 34 years; gestational age range, 16 to 36 weeks) undergoing transcatheterembolotherapy.
Transcatheterembolotherapy in all patients.
Thirteen pulmonary arteriovenous malformations in sevenpatients were embolized with detachable silicone balloons and/orstainless steel coils without incident. The estimated fetal radiationdose ranged from < 50 to 220 mrad. No complications of pulmonaryarteriovenous malformations occurred in any of the patients aftertranscatheter embolotherapy. The mothers went on to deliver healthybabies in all cases.
Transcatheterembolotherapy of maternal pulmonary arteriovenous malformationsperformed by an experienced radiologist appears to be safe andeffective after 16 weeks of gestational age.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.119.2.470</identifier><identifier>PMID: 11171725</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Arteriovenous Malformations - therapy ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Embolization, Therapeutic ; Female ; Humans ; Medical sciences ; Pregnancy ; Pregnancy Complications, Cardiovascular - therapy ; pulmonary arteriovenous malformations ; Pulmonary Artery - abnormalities ; Pulmonary Veins - abnormalities ; transcatheter embolotherapy</subject><ispartof>Chest, 2001-02, Vol.119 (2), p.470-477</ispartof><rights>2001 The American College of Chest Physicians</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-6c02e0391f58add076e91f70e9f849172b71c235009b2cc897452c6644e9bf513</citedby><cites>FETCH-LOGICAL-c392t-6c02e0391f58add076e91f70e9f849172b71c235009b2cc897452c6644e9bf513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=894192$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11171725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gershon, Andrea S.</creatorcontrib><creatorcontrib>Faughnan, Marie E.</creatorcontrib><creatorcontrib>Chon, Kenneth S.</creatorcontrib><creatorcontrib>Pugash, Robyn A.</creatorcontrib><creatorcontrib>Clark, John A.</creatorcontrib><creatorcontrib>Bohan, Michael J.</creatorcontrib><creatorcontrib>Henderson, Katherine J.</creatorcontrib><creatorcontrib>Hyland, Robert H.</creatorcontrib><creatorcontrib>White, Robert I.</creatorcontrib><title>Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy</title><title>Chest</title><addtitle>Chest</addtitle><description>To determine if transcatheterembolotherapy is safe and effective for the treatment of pulmonaryarteriovenous malformations during pregnancy.
Prospective study.
Specialized hereditaryhemorrhagic telangiectasia centers at Yale University School of, Medicine and St. Michael's Hospital, University of Toronto.
Seven pregnant women (age range, 24 to 34 years; gestational age range, 16 to 36 weeks) undergoing transcatheterembolotherapy.
Transcatheterembolotherapy in all patients.
Thirteen pulmonary arteriovenous malformations in sevenpatients were embolized with detachable silicone balloons and/orstainless steel coils without incident. The estimated fetal radiationdose ranged from < 50 to 220 mrad. No complications of pulmonaryarteriovenous malformations occurred in any of the patients aftertranscatheter embolotherapy. The mothers went on to deliver healthybabies in all cases.
Transcatheterembolotherapy of maternal pulmonary arteriovenous malformationsperformed by an experienced radiologist appears to be safe andeffective after 16 weeks of gestational age.</description><subject>Adult</subject><subject>Arteriovenous Malformations - therapy</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Embolization, Therapeutic</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Cardiovascular - therapy</subject><subject>pulmonary arteriovenous malformations</subject><subject>Pulmonary Artery - abnormalities</subject><subject>Pulmonary Veins - abnormalities</subject><subject>transcatheter embolotherapy</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtP3DAQgC1EVRbomRuKhNRbFj-SOD4ioLQSVTnQK5bjTHaNHHuxE6r99x26q9JLT_aMvnl9hJwxumRCtpd2DXlaMqaWfFlJekAWTAlWiroSh2RBKeOlaBQ_Isc5P1OMmWo-kiPGmGSS1wvy9JhMyNZMa5ggFbdjF33EIJnNtohD8d1gOhhfPMx-jMGkbXGVMOXiK4Q4ZwT8ENNoJhdDLm7m5MKqeEiwCibY7Sn5MBif4dP-PSE_v9w-Xn8t73_cfbu-ui-tUHwqG0s5UKHYULem76lsAP-SghraSuGmnWSWi5pS1XFrWyWrmtumqSpQ3VAzcUI-7_puUnyZ0YkeXbbgvQmAW2pJG17TtkXwcgfaFHNOMOhNciOepRnVb0r1H6UaRWmuUSlWnO9bz90I_Tu_d4jAxR4wKNIPKNS6_JdrVcUUfx-8dqv1L5dA59F4j03FbuRznN9E_ztY7SoAxb06SDpbB8FCj9V20n10_136N8TKpR0</recordid><startdate>200102</startdate><enddate>200102</enddate><creator>Gershon, Andrea S.</creator><creator>Faughnan, Marie E.</creator><creator>Chon, Kenneth S.</creator><creator>Pugash, Robyn A.</creator><creator>Clark, John A.</creator><creator>Bohan, Michael J.</creator><creator>Henderson, Katherine J.</creator><creator>Hyland, Robert H.</creator><creator>White, Robert I.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200102</creationdate><title>Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy</title><author>Gershon, Andrea S. ; Faughnan, Marie E. ; Chon, Kenneth S. ; Pugash, Robyn A. ; Clark, John A. ; Bohan, Michael J. ; Henderson, Katherine J. ; Hyland, Robert H. ; White, Robert I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-6c02e0391f58add076e91f70e9f849172b71c235009b2cc897452c6644e9bf513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Arteriovenous Malformations - therapy</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Embolization, Therapeutic</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Cardiovascular - therapy</topic><topic>pulmonary arteriovenous malformations</topic><topic>Pulmonary Artery - abnormalities</topic><topic>Pulmonary Veins - abnormalities</topic><topic>transcatheter embolotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gershon, Andrea S.</creatorcontrib><creatorcontrib>Faughnan, Marie E.</creatorcontrib><creatorcontrib>Chon, Kenneth S.</creatorcontrib><creatorcontrib>Pugash, Robyn A.</creatorcontrib><creatorcontrib>Clark, John A.</creatorcontrib><creatorcontrib>Bohan, Michael J.</creatorcontrib><creatorcontrib>Henderson, Katherine J.</creatorcontrib><creatorcontrib>Hyland, Robert H.</creatorcontrib><creatorcontrib>White, Robert I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gershon, Andrea S.</au><au>Faughnan, Marie E.</au><au>Chon, Kenneth S.</au><au>Pugash, Robyn A.</au><au>Clark, John A.</au><au>Bohan, Michael J.</au><au>Henderson, Katherine J.</au><au>Hyland, Robert H.</au><au>White, Robert I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2001-02</date><risdate>2001</risdate><volume>119</volume><issue>2</issue><spage>470</spage><epage>477</epage><pages>470-477</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>To determine if transcatheterembolotherapy is safe and effective for the treatment of pulmonaryarteriovenous malformations during pregnancy.
Prospective study.
Specialized hereditaryhemorrhagic telangiectasia centers at Yale University School of, Medicine and St. Michael's Hospital, University of Toronto.
Seven pregnant women (age range, 24 to 34 years; gestational age range, 16 to 36 weeks) undergoing transcatheterembolotherapy.
Transcatheterembolotherapy in all patients.
Thirteen pulmonary arteriovenous malformations in sevenpatients were embolized with detachable silicone balloons and/orstainless steel coils without incident. The estimated fetal radiationdose ranged from < 50 to 220 mrad. No complications of pulmonaryarteriovenous malformations occurred in any of the patients aftertranscatheter embolotherapy. The mothers went on to deliver healthybabies in all cases.
Transcatheterembolotherapy of maternal pulmonary arteriovenous malformationsperformed by an experienced radiologist appears to be safe andeffective after 16 weeks of gestational age.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>11171725</pmid><doi>10.1378/chest.119.2.470</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-3692 |
| ispartof | Chest, 2001-02, Vol.119 (2), p.470-477 |
| issn | 0012-3692 1931-3543 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70625088 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adult Arteriovenous Malformations - therapy Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Embolization, Therapeutic Female Humans Medical sciences Pregnancy Pregnancy Complications, Cardiovascular - therapy pulmonary arteriovenous malformations Pulmonary Artery - abnormalities Pulmonary Veins - abnormalities transcatheter embolotherapy |
| title | Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformations During Pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A57%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcatheter%20Embolotherapy%20of%20Maternal%20Pulmonary%20Arteriovenous%20Malformations%20During%20Pregnancy&rft.jtitle=Chest&rft.au=Gershon,%20Andrea%20S.&rft.date=2001-02&rft.volume=119&rft.issue=2&rft.spage=470&rft.epage=477&rft.pages=470-477&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.119.2.470&rft_dat=%3Cproquest_cross%3E70625088%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70625088&rft_id=info:pmid/11171725&rft_els_id=S0012369215382246&rfr_iscdi=true |